Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · IEX Real-Time Price · USD

222.26

-6.08 (-2.66%)

At close: Apr 18, 2024, 4:00 PM

221.99

-0.27 (-0.12%)

After-hours: Apr 18, 2024, 6:05 PM EDT

Madrigal Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Net Income	-373.63	-295.35	-241.85	-202.24	-83.95	-32.81	-31.15	-26.39	-6.84	-86.16	Upgrade
Depreciation & Amortization	0.53	0.47	0.41	0.47	0.11	0.1	0.08	0	0	0.67	Upgrade
Share-Based Compensation	49.74	31.63	26.87	20.73	22.76	13.49	3.25	8.68	0	7.43	Upgrade
Other Operating Activities	-0.86	38.4	30.65	23.48	19.45	-6.28	5.51	0.1	3.7	-0.87	Upgrade
Operating Cash Flow	-324.23	-224.86	-183.92	-157.56	-41.62	-25.51	-22.32	-17.61	-3.14	-78.93	Upgrade
Capital Expenditures	-1.48	-0.22	-0.21	-0.33	-0.17	-0.02	-0.13	0.7	0	-0.14	Upgrade
Acquisitions	0	0	0	0	0	0	0	5.85	0	0	Upgrade
Change in Investments	-501.04	206.9	-4.85	160.11	30.88	-380.05	-21.88	15.37	0	-8.69	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	0.08	-	-	Upgrade
Investing Cash Flow	-502.52	206.69	-5.06	159.78	30.71	-380.08	-22.01	21.99	0	-8.84	Upgrade
Share Issuance / Repurchase	530.48	264.34	171.24	5.09	0.24	314.34	173.81	5.95	0	94.79	Upgrade
Debt Issued / Paid	64.64	49.11	0	0	0	0	0	8.5	3.3	-9.49	Upgrade
Financing Cash Flow	595.12	313.45	171.24	5.09	0.24	314.34	173.81	14.45	3.3	85.3	Upgrade
Net Cash Flow	-231.63	295.28	-17.74	7.31	-10.68	-91.25	129.48	18.84	0.16	-2.47	Upgrade
Free Cash Flow	-325.71	-225.07	-184.13	-157.9	-41.8	-25.53	-22.44	-16.91	-3.14	-79.07	Upgrade
Free Cash Flow Per Share	-17.43	-13.13	-11.13	-10.22	-2.71	-1.73	-1.83	-3.25	-18.37	-28.10	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).